[1] Ford ES. Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U. S. adults from 1999to 2010[J]. J Am Coll Cardiol, 2013, 61(22):2249-2252. [2] 陈伟伟, 高润霖, 刘力生, 等. 中国心血管病报告2013概要[J]. 中国循环杂志, 2014, 29(7):487-491. [3] Baigent C, Blackwell L, Collins R, et al. Aspirin in the pri-mary and secondary prevention of vascular disease:collabora-tive meta-analysisof individual participant data from ran-domised trials[J]. Lancet, 2009, 373(9678):1849-1860. [4] Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J]. N Engl J Med, 2001, 345(7):494-502. [5] Garcia Rodriguez LA, Lin KJ, Hernandez-Diaz S, et al. Risk of upper gastrointestinal bleeding with low-dose acetyl-salicylic acid alone and in combination with clopidogrel and other medications[J]. Circulation, 2011, 123(10):1108-1115. [6] Hallas J, Dall M, Andries A, et al. Use of single and com-bined antithrombotic therapy and risk of serious upper gas-trointestinal bleeding:population based case-control study[J]. BMJ, 2006, 333(7571):726. [7] Metzler H, Kozek-Langenecker S, Huber K. Antiplatelet therapy and coronary stents in perioperative medicine-the two sides of the coin[J]. Best Pract Res Clin Anaesthesiol, 2008, 22(1):81-94. [8] Oh HG. Management of Antithrombotic Therapy for Gastroen-terological Endoscopy from a Cardio-Cerebrovascular Physi-cian's Point of View[J]. Clin Endos, 2014, 47(4):320-323. [9] 崔华, 范利, 张梦, 等. 住院老年高血压患者死亡相关因素的分析[J]. 中国应用生理学杂志, 2014, 30(1):64-68. [10] Witt DM, Delate T, McCool KH, et al. Incidence and pre-dictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy[J]. J Thromb Haemost, 2009, 7(12):1982-1989. [11] Veitch AM, Baglin TP, Gershlick AH, et al. British Society of Gastroenterology; British Committee for Standards in Haematology; British Cardiovascular Intervention Society. Guidelines for the management of anticoagulant and an-tiplatelet therapy in patients undergoing endoscopic procedures[J]. Gut, 2008, 57(9):1322-1329. [12] ASGE Standards of Practice Committee, Anderson MA, Ben-Menachem T, et al. Management of antithrombotic agents for endoscopic procedures[J]. Gastrointest Endosc, 2009, 70(6):1060-1070. [13] Boustière C, Veitch A, Vanbiervliet G, et al. European So-ciety of Gastrointestinal Endoscopy. Endoscopy and an-tiplatelet agents. European Society of Gastrointestinal En-doscopy (ESGE) Guideline[J]. Endoscopy, 2011, 43(5):445-461. [14] Fujimoto K, Fujishiro M, Kato M, et al. Japan Gastroen-terological Endoscopy Society. Guidelines for gastroenterolo-gical endoscopy in patients undergoing antithrombotic treat-ment[J]. Dig Endosc, 2014, 26(1):1-14. [15] Chassot PG, Delabays A, Spahn DR. Perioperative an-tiplatelet therapy:the case for continuing therapy in patients at risk of myocardial infarction[J]. Br J Anaesth, 2007, 99(3):316-328. [16] Chassot PG, Delabays A, Spahn DR. Perioperative an-tiplatelet therapy:the case for continuing therapy in patients at risk of myocardial infarction[J]. Br J Anaesth, 2007, 99(3):316-328. [17] 赵晓宁, 王玉堂. 老年患者PICC导管相关性上肢深静脉血栓治疗的影响因素[J]. 中国应用生理学杂志, 2016, (32)2:124-127. [18] Assaad B, Sesi VK, Figari R, et al. Antithrombotic man-agement of stroke patients before colonoscopy. Journal of stroke and cerebrovascular diseases[J]. J Stroke Cerebrovasc Dis, 2013, 22(6):733-736. [19] Smith LE. Fiberoptic colonoscopy:complications of colonoscopy and polypectomy[J]. Dis Colon Rectum, 1976, 19(5):407-412. [20] Rosen L, Bub DS, Reed JF 3rd, et al. Hemorrhage follow-ing colonoscopic polypectomy[J]. Dis Colon Rectum, 1993, 36(12):1126-1131. [21] Nelson DB, McQuaid KR, Bond JH, et al. Procedural suc-cess and complications of large-scale screening colonoscopy[J]. Gastrointest Endosc, 2002, 55(3):307-314. [22] Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospec-tive evaluation of complications in outpatient GI endoscopy:a survey among German gastroenterologists[J]. Gastrointest En-dosc, 2001, 53(6):620-627. [23] Sung JJ, Lau JY, Ching JY, et al. Continuation of low dose aspirin therapy in peptic bleeding[J]. Ann Intern Med, 2010, 152(1):1-9. [24] Derogar M, Sandblom G, Lundell L, et al. Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increas-es risk of death and acute cardiovascular events[J]. Clin Gastroenterol Hepatol, 2013, 11(1):38-42. [25] Carter D, Beer-Gabel M, Eliakim R, et al. Management of antithrombotic agents for colonoscopic polypectomies in Israeli gastroenterologists relative to published guidelines[J]. Clin Res Hepatol Gastroenterol, 2013, 37(5):514-518. |